Search Results

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV

• Source: A Study Investigating the Pharmacokinetic Properties When Dosing Different Formulations of Semaglutide to Healthy Male Participants

Record details

Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy

• Authors : Di Costanzo A; Loreto L; Vassallo C

Subjects: economic evaluation; cost analysis; intravenous therapy

• Source: ClinicoEconomics and Outcomes Research, Vol Volume 17, Pp 171-187 (2025)

Record details

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III

• Source: A Study Investigating the Pharmacokinetic Properties When Dosing Different Formulations of Semaglutide to Healthy Male Participants - Oral

Record details

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

• Source: Sustained Release Oral Formulation for Treatment of Parkinson's Disease

Record details

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II

• Source: A Study Investigating the Pharmacokinetic Properties When Dosing Different Formulations of NNC0385-0434 to Healthy Male Participants - Oral

Record details

Designing a sustained-release solid oral formulation for overactive bladder treatment: a quality by design approach

• Authors : Neeraj Sharma; Daksh Bhatia; Sharda Shambhakar

Subjects: overactive bladder; quality by design; mirabegron

• Source: Journal of Applied Pharmaceutical Research, Vol 13, Iss 1, Pp 123-135 (2025)

Record details

Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.

• Authors : Marques Vidas, María^1,2 (AUTHOR) ; López-Sánchez, Paula¹ (AUTHOR) ; Sánchez-Briales, Paula¹ (AUTHOR)

• Source: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5166. 9p.

Record details

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.

• Authors : De Angelis, Maria Laura¹ (AUTHOR); Francescangeli, Federica¹ (AUTHOR); Aricò, Eleonora¹ (AUTHOR)

• Source: Journal of Experimental & Clinical Cancer Research (17569966). 11/5/2024, p1-20. 20p.

Record details

ORAL FORMULATION OF A PYRIDINONE DERIVATE AND USE THEREOF IN PROPHYLAXIS AND/OR TREATMENT OF INTESTINAL FIBROSIS

Record details

CONTROLLED-RELEASE ORAL FORMULATION AND PREPARATION METHOD THEREOF

Record details